Searchable abstracts of presentations at key conferences in endocrinology

ea0021p128 | Cytokines and growth factors | SFEBES2009

Blood pressure, renal cytokines and biochemical parameters improve in morbidly obese patients after bariatric surgery

Dubb Sukhpreet Singh , Bueter Marco , Gill Abhijit , Ahmed Ahmed R , Frankel Andrew , Le Roux Carel W , Tam Frederick

Introduction: Obesity related glomerulopathy (ORG) is an emerging epidemic alongside increasing incidences of obesity. ORG pathophysiology has not been explored despite poor prognosis in untreated patients. MCP-1, MIF, CCL-18 and CCL-15 are novel cytokines that may be pathologically involved in obesity-induced renal injury and explored in this study.Methods: Blood pressure, urine and blood samples were collected from 34 morbidly obese patients before and...

ea0086op4.1 | Metabolism, Obesity and Diabetes | SFEBES2022

The effects of a tripeptide hormonal infusion on sweet taste function and eating behaviour

Behary Preeshila , Alessmii Haya , Miras Alexander , Tharakan George , Alexiadou Kleopatra , Purkayastha Sanjay , Moorthy Krishna , R Ahmed Ahmed , Bloom Stephen R , Tan Tricia M

Background: Roux-en-Y Gastric Bypass (RYGB) results in sustained weight loss. Changes in food preferences and eating behaviour are postulated as possible contributing mechanisms. Post-RYGB, patients consume less sugary and fatty food. Sweet taste detection and sensitivity have been reported to be enhanced post-surgery and this may account for changes in the palatability of food. Underlying mechanisms for the changes in sweet taste function and eating behaviour are unclear....

ea0067o24 | Oral Presentations | EYES2019

Proglucagon peptide family responses after RYGB surgery in obese patients with type 2 diabetes

Alexiadou Kleopatra , Cuenco Joyceline , Howard James W , Fleuret Matthieu , Behary Preeshila , Tharakan George , Albrechtsen Nicolai J Wewer , Holst Jens Juul , Pembroke Jason , Wheller Robert , Ahmed Ahmed R , Bloom Steve R , Tan Tricia M

Objective: Bariatric surgery is currently the most effective treatment for weight loss and diabetes remission. There are conflicting reports in the literature regarding the glucagon levels after RYGB surgery, likely due to cross-reactivity with oxyntomodulin and glicentin. The aim of this study was to characterize the proglucagon peptide family responses post-RYGB surgery in obese patients with type 2 diabetes using validated assays.Method: Nineteen obes...